The Truth About Using Drugs to Cure Osteoporosis

If nothing is done, bone problems could get worse and turn into agonizing and unbearable bone problems causing confinement or worse. This essay looks for answers to some key questions concerning the use of drugs in treating bone problems. People experience a reduction in mineral density in their bones, as a result either because of the normal wear of age, or as a result of lack of calcium. In its more advanced stage, this decline in bone density is described as Osteoporosis, where the bones become porous and fracture easily.

Are Physicians Overusing An Invasive Cardiac Treatment?

Researchers are asking if cardiology patients receive intervention-type treatments, such as stents, too often and too quickly.

In regions of the country where cardiologists perform high numbers of cardiac catheterizations to diagnose heart problems, patients may be receiving a treatment known as percutaneous cardiac intervention (PCI) more than they need or want, according to a study published online this week in the journal Circulation. The study will also be in the journal's December 16/23 print edition.

read more

More at...

New data released today demonstrate that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.

read more

More at...

The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "Treatment of Osteoarthritis of the Knee". These guidelines were explicitly developed to include only treatments which are less invasive than knee replacement surgery. While a wide range of treatment options are available, they should always be tailored to individual patients after discussions with their physicians.

The Guidelines and Evidence Report recommends:

read more

More at...

New Way Of Viewing Cells Could Lead To Easier Routes For Drug Manufacture

Research by a Michigan State University chemist could eventually lead to a quicker and easier way of developing protein-based drugs that are key to treating a number of diseases, including cancer, diabetes and hepatitis. Proteins used in drug manufacture and research often are made within genetically modified Escherichia coli, a one-cell bacteria. That protein tends to collect into what scientists call inclusion bodies. More at...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has formed an exclusive collaboration with the University of California, San Francisco (UCSF) to evaluate the potential of an RNAi therapeutic targeting a heterotrimeric G protein alpha-subunit, known as G-alpha q or GNAQ, for the treatment of metastatic uveal melanoma. More at...

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced it submitted the first of three modules of its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the LightTouchTM non-invasive cervical cancer detection device. More at...

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that multiple studies of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) will be presented at the 31st Annual San Antonio Breast Cancer Symposium on December 10-14, 2008. More at...